InvestorsObserver’s 46 rating of Novavax, Inc. (NVAX) stock places it close to the top of the biotechnology industry. In addition to rating more than 73 percent of stocks in the biotech industry, NVAX’s overall rating of 46 means the stock does better than 46 percent of all stocks.
Copyright © 2021. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer and / or O2 Media LLC. All rights reserved. Portions of this content are protected by U.S. Patent Nos. 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, options, and other financial instruments carries risks and may not be suitable for everyone. The portfolio results are unaudited and are based on different expiration dates of the plant. Terms of Use | Privacy Policy
Keywords:
